Radiopharmaceutical Market Projected To Reach USD 11.2 Bn By 2032, With Cagr Of 7%
A radiopharmaceutical is a pharmaceutical medication containing a radioactive substance, also known as a radionuclide or radiotracer. It is utilized for diagnostic or therapeutic purposes in nuclear medicine. Radiopharmaceuticals combine the characteristics of a specific pharmaceutical agent with the ability to emit radiation, enabling targeted imaging or treatment of a variety of medical conditions. Injection, inhalation, and oral administration of radiopharmaceuticals are all methods of administration. The radiopharmaceutical contains a radioactive substance that emanates gamma rays or positrons, which can be detected by gamma cameras or positron emission tomography (PET) scanners. These imaging techniques provide detailed information regarding the function…
- Date: July 10, 2023
- Author: Robert Shaw
- Category: Taiwan News